OSI has backed digital wellness technology company BioBeats, which was founded by University of Surrey faculty and counts multiple corporates among its shareholders.

Sensyne Health has completed a $76m initial public offering and will begin trading on Aim tomorrow, offering an exit to University of Oxford.

David Paterson, once the director of tech transfer at Pennsylvania State University, has rejoined the academic world by accepting a position as assistant vice-president at CSU.

The genomic drug developer has secured $15m in a pre-series B round led by Lilly Asia Ventures that included Huagai Capital, IDG Capital and WI Harper.

Maxim Integrated and Tasly Pharmaceutical contributed to Profusa's series C round, which will fund commercialisation of its biosensor technology.

IU spinout Care Revolution has been backed by the university's Philanthropic Venture Fund after previously raising funds in 2016.

Oscar Health has received funding from existing backer Alphabet, which acquired a 10% stake in the health insurer through the deal.

Tracy Saxton, formerly of Roche Venture Fund and Pivotal BioVenture Partners, has joined Frazier Healthcare Partners as an entrepreneur-in-residence.

Sphera Global Health Care and Medison were among the participants in a round that took Orchard Therapeutics' overall funding past $290m.